Compounds > dicloxacillin

Page last updated: 2024-08-22

dicloxacillin and cefoxitin

dicloxacillin has been researched along with cefoxitin in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (14.29)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (42.86)	29.6817
2010's	2 (28.57)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I	1
Lombardo, F; Obach, RS; Waters, NJ	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Craig, WA; Elliott, RL; England, AC; Suh, B	1
Dilworth, T; Hernandez, BN; Kesner, J; Mercier, RC; Ryan, K; Thelen, H	1

Reviews

1 review(s) available for dicloxacillin and cefoxitin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

6 other study(ies) available for dicloxacillin and cefoxitin

Article	Year
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1. Journal of medicinal chemistry, 2005, Jun-30, Volume: 48, Issue:13 Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters	2005
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics. Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:4 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship	2013
Effect of free fatty acids on protein binding of antimicrobial agents. The Journal of infectious diseases, 1981, Volume: 143, Issue:4 Topics: Anti-Bacterial Agents; Cefamandole; Cefoxitin; Cephalothin; Chloramphenicol; Clindamycin; Dicloxacillin; Fatty Acids, Nonesterified; Humans; Penicillin G; Protein Binding; Serum Albumin; Sulfamethoxazole; Trimethoprim	1981
MIC Discrepancies between Parenteral and Oral Anti-Staphylococcal Beta-Lactams among MSSA. Chemotherapy, 2023, Volume: 68, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefoxitin; Cephalexin; Dicloxacillin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monobactams; Oxacillin; Staphylococcal Infections; Staphylococcus aureus	2023